Nuclear aggregates of polyglutamine (polyQ)-expanded proteins are associated with a number of neurodegenerative diseases including Huntington's disease (HD) and spinocerebellar ataxias (SCAs). The nuclear deposition of polyQ proteins correlates with rearrangements of nuclear matrix, transcriptional dysregulation, and cell death. To explore the requirement for polyQ tracks in educing such cellular responses, we examined whether a non-polyQ protein can deposit as nuclear aggregates and elicit similar responses. We report that a protein chimera (GFP170*) composed of the green fluorescent protein (GFP) fused to an internal fragment of the Golgi Complex Protein (GCP-170) forms nuclear aggregates analogous to those formed by polyQ proteins. Like the polyQ nuclear aggregates, GFP170* inclusions recruit molecular chaperones and proteasomal components, alter nuclear structures containing the promyelocytic leukemia protein (PML), recruit transcriptional factors such as CREB-binding protein (CBP) and p53, repress p53 transcriptional activity, and induce cell death. Our results indicate that nuclear aggregation and transcriptional effects are not unique to polyQ-containing proteins and may represent a general response to misfolded proteins in the nucleus. D
Introduction
At least nine neurodegenerative diseases, including Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA), and spinocerebellar ataxias (SCA) 1, 2, 3, 6, 7, and 17, are caused by a single type of mutation, the expansion of CAG repeats encoding for a polyglutamine (polyQ) track in unrelated proteins (Zoghbi and Orr, 2000) . The mutant proteins form protein aggregates or inclusions that are the hallmark of polyQ diseases (Ross, 2002) . Unlike other mutant proteins that form cytoplasmic aggregates in diseases such as Alzheimer' and Parkinson's diseases or amyotrophic lateral sclerosis, polyQ proteins can be deposited as cytoplasmic inclusions as well as nuclear inclusions. The nuclear deposition of polyQ proteins has been correlated with cytotoxicity. Transgenic mice expressing polyQ human huntingtin develop neuronal intranuclear inclusions prior to developing a neurological phenotype (Davies et al., 1997) . Similarly, nuclear localization of polyQ proteins is essential to induce cell death in cultured cell and transgenic mouse models (Katsuno et al., 2002; Klement et al., 1998; Takeyama et al., 2002) . However, the exact correlation between nuclear polyQ aggregates and pathology remains elusive. It is apparent that not all neurons containing polyQ aggregates die (Ross et al., 1998) , and temporal studies of the appearance of aggregates and the onset of clinical pathology suggest that tissue damage and pathology can manifest before detection of aggregates (Saudou et al., 1998) .
PolyQ pathogenesis may be linked to the sequestration and inactivation of proteins essential for cellular functions. Analyses of human post-mortem brains, animal models, and cell culture systems have shown that polyQ deposits recruit various cellular components. Invariably, proteins involved in protein folding and degradation, as well as transcriptional regulators are associated with polyQ aggregates (Li and Li, 2004) . All the major classes of chaperones including members of the Hsp70 family (Hsc70 and Hsp70) and the Hsp40 family (Hdj1 and Hdj2) are recruited. Like chaperones, proteasomes have been shown to be associated with polyQ aggregates (Waelter et al., 2001) . Often, polyQ inclusions are ubiquitin positive (DiFiglia et al., 1997) . The sequestration of folding/degradative machinery to protein aggregates results in compromised proteasomal degradation (Bence et al., 2001) .
Nuclear factors also have been shown to interact with polyQ nuclear inclusions (Okazawa, 2003) . Nuclear aggregates of ataxin-1 recruit the promyelocytic leukemia protein (PML), a component of nuclear PML bodies (Skinner et al., 1997) . Direct association of the CREB binding protein (CBP) with polyQ aggregates has been observed in HD cell culture models, HD transgenic mice, and human HD post-mortem brain (Nucifora et al., 2001 ). Sp1 and p53 also interact with polyQ huntingtin fragments (Nucifora et al., 2001; Steffan et al., 2000) . 
